Shire Share Discussion Threads

[justiceforthemany] 02/9/2017 08:20

A technical marker for showing how 'oversold' or 'overbought' a share is.

Can be helpful for knowing when to buy or sell.

RSI > 70 = overbought
RSI < 30 = oversold

Provident recently crashed to an RSI of 5. Within 2 days the price had doubled and RSI was up at 20+

DC Dixons Carphone has a current RSI of just 10 after a massive sell off.
It should rebound well from here.

[ruethewhirl] 01/9/2017 21:06

Nice uplift.

Justice, what's RSI?

[justiceforthemany] 01/9/2017 19:38

Any thoughts on Premier Foods? Current share price 40p. Debt remains high but it has a good portfolio of big brands. Directors are buying and they received a 65p/share only last year which was turned down so directors seem confident of a turnaround.

[justiceforthemany] 01/9/2017 18:34

Buyers clearly have returned here but it fell so far that most PI's are still probably under water.

RSI now in low 50's having fallen to low 20's.

Wider FTSE up 0.6% on the week recovering somewhat after the horror show on Tuesday which the US somehow escaped - I thought it was the US & Trump battling North Korea not us?!

Portfolio up 1.1% again mainly due to this + CINE, PHTM, GOG, GNC, GSK, AZN.
ITV, VEC, DC, WPP, DEB have been disasters so far but most if not all look oversold IMO.

DC has an RSI of only 10 currently which is very low.
ITV ditto + a takeover candidate.
Both yield 6-7% currently.

Had not heard of SSPG so had a quick look into the fundamentals. I know it's being tipped and is a growth share but a P/E around 40 seems very high to me. Assets of £1.3Bn with £700M in intangibles/goodwill and £1Bn Debt is also not great.

Should have bought ABF when it was in the mid 20's.
Bought MKS at 307 this week although shorts >10% are both puzzling and worrying.

[philanderer] 01/9/2017 17:41

Good week for SHP +183p , and the portfolio :-)

portfolio +1.4%

ftse100 +0.5%

ftse250 +0.6%


SHP, ABF, SSPG, BVIC and MKS doing the business for me. Just one in the red TSCO -1p


Good weekend everyone.

[romeike] 01/9/2017 11:35

Are they seriously using Glassdoor as an accurate source for investment decisions? Really? What next, trawling the CafePharma forums for signs of discontent?

Next stop is £42. Last time it dipped to £36 on the back of blatant shorting it was back near £50 within weeks. Though last time there was no threat of nuclear war.

[essentialinvestor] 01/9/2017 11:23

While employee surveys may be useful,
I would keep in mind this coincides with a time of rapid change for the group.
Just my take.

[justiceforthemany] 31/8/2017 20:38

Nice day for the portfolio for a change. Up 1.4% Vs 0.9% for the wider FTSE. Even this has done well today. Let's hope it continues. Up 2.5% in the US.

[philanderer] 31/8/2017 16:02

About time too ;-)

[ruethewhirl] 31/8/2017 11:12

What's this I see? Couldn't be could it? No? A.... rally?

[philanderer] 31/8/2017 09:20

Shire launches newest ADHD med Mydayis

[philanderer] 30/8/2017 15:49

Shire : defends record as UBS cuts price target on staff satisfaction reviews


Shire is weathering a period a major change well, the company said on Tuesday, as analysts at UBS cut their price target on the stock in response to signs of falling staff satisfaction at the drugmaker.
A trawl of 20,000 employee reviews from careers website Glassdoor showed a major decline in staff satisfaction at Shire in 2017, with the company coming 24th out of 26 biopharmaceutical companies on "overall satisfaction", UBS said.

Shire, which recently lost its chief financial officer and head of research, faces testing times after buying United States-based Baxalta in its biggest ever deal, leading to inevitable upheaval and challenges.

In 2015 and 2016 Shire and Baxalta were just below the middle of the pack on most employee satisfaction measures.

"Neither markets nor employees seem as confident as management that things are on track," UBS said, reducing its 12-month price target to 40.95 pounds a share from 45 pounds while rating the stock neutral.

Shire's chief human resources officer, Joanne Cordeiro, said the drugmaker's own surveys painted a more encouraging picture.

"We are in the late stages of significant corporate transformation as we have evolved into the global leader in rare diseases," she said.

"Our internal engagement marks for Shire are high despite these changes. We are focussed on working to ensure we continue to build the best organisation for our employees, patients and shareholders."

[philanderer] 29/8/2017 17:15

Folio matched the FTSE250 today -0.7% :-(

SHP almost matching that -0.6%

[philanderer] 29/8/2017 11:00

29th august UBS ' neutral' tp 4095p cut from 4500p

[philanderer] 29/8/2017 09:27

That's a bad start to the week , portfolio tw@tted by 0.9%.... just one up...Dominos Pizza !

[steeplejack] 28/8/2017 16:34

Currency is a big consideration when it comes to determining strategy.One of the reasons that the Euro is going better is because money is flowing out of the US into Euro denominated markets.If a US fund deals in the UK,they are necessarily making a commitment to dog-eared sterling.You might think that ultimately the Nasdaq and US quotes equalise and ultimately they might.However,If a US fund had been predominantly dealing in sterling designated Shire stock over the last couple of years,it's stockholders wouldn't be overly pleased I suspect.Even the dollar has been weak of late of course,but where currency is concerned,the Shire Nasdaq quote almost certainly holds sway here.

[romeike] 26/8/2017 13:41

I fail to see why US Open and the FTSE would be related. Any American getting up early can trade on FTSE. There isn't anything making them wait until the US markets open. I don't see the connection at all.

[philanderer] 25/8/2017 21:41

London Ev Standard, Market report.....


Among the risers on the FTSE 100 was Shire after Cantor Fitzgerald repeated its Buy rating, questioning the recent share price decline.

“We believe that the breadth of Shire’s portfolio as well as its exposure to market segments with visible growth characteristics have been overshadowed,” the broker said.

[philanderer] 25/8/2017 18:03

justice, well done on that, just a small nudge up for me.

+0.42% portfolio

+0.22% ftse 250

+ 1.0% ftse 100

[justiceforthemany] 25/8/2017 17:28

philanderer up 2.2% on the portfolio this week vs 1% rise for the FTSE350. Shire and Hikma mainly behind this although Shire in particular remains highly oversold IMO as do Greencore and ITV.

[justiceforthemany] 25/8/2017 16:57

So I was right once again - US opens and this tanks yet again

[romeike] 25/8/2017 15:42

This morning's rally is getting pushed down into the close

[philanderer] 25/8/2017 13:15

Shire in collaboration with MicroHealth on haemophilia monitoring tool

[mbmiah] 25/8/2017 12:04

£36 will do

[romeike] 25/8/2017 11:37

I've been trading Shire since before the millennium started. Excepting for some kind of global collapse I don't think you'll be seeing £35 again any time soon.